Review Article

The Human Skin-Derived Precursors for Regenerative Medicine: Current State, Challenges, and Perspectives

Table 3

The protocols for neurogenesis of hSKPs.

DifferentiationBasic mediumReagent (concentration)IndicationRef.

Neuron differentiationNeurobasal or DMEM/F12 (3 : 1) mediumBrain-derived neutrophic factor (50 ng/ml), nerve growth factor (50 ng/ml), neurotrophiin-3 (10 ng/ml), FBS (1%–5%)Differentiation for 2–4 weeks with 50% of the medium changed every 3-4 days[6]
Schwann cell differentiationNeurobasal or DMEM/F12 (3 : 1) mediumN2 supplement (1% or 2%), forskolin (4 μm or 5 μm), heregulinβ (10 ng/ml or 50 ng/ml), FBS (1%)Differentiation for 2–4 weeks with 50% of the medium changed every 3-4 days[6, 34]
Astrocyte differentiationB27 neurobasal mediumFBS (3%–10%)Differentiation for 3 weeks with 50% of the medium changed every 3-4 days[32]

DMEM: Dulbecco’s modified Eagle medium; FBS: fetal bovine serum.